Literature DB >> 26379928

Prothrombin C20209T mutation in deep vein thrombosis: a case report.

Mariela Muñoz1, Cristian Vilos2, Mario Cantín3.   

Abstract

Thrombophilias is a recognized risk factor for thrombotic events. The prothrombin variant G20210A gene mutation has been commonly examined using polymerase chain reaction (PCR). Currently, in many clinical laboratories, performing the PCR in real-time technique, which, in addition to identifying the G20210A mutation, makes possible the detection of other mutations in the 3'UTR of the prothrombin gene by melting curve analysis, due to the ability of this analysis to be amplicon-dependent (e.g., C20209T, C20221T and A20218G). We report the first case in Chile that describes the atypical prothrombin C20209T mutation, in a 50-year-old male patient diagnosed with deep vein thrombosis in the lower limb and family history of thrombophilia. In the literature, there are few studies of the prevalence and functionality of this mutation; its association with thrombotic events is controversial.

Entities:  

Keywords:  3’Untranslated region; C20209T; mutation; prothrombin; thrombophilia

Year:  2015        PMID: 26379928      PMCID: PMC4565311     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia.

Authors:  N H Gehring; U Frede; G Neu-Yilik; P Hundsdoerfer; B Vetter; M W Hentze; A E Kulozik
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

2.  The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations.

Authors:  Sven Danckwardt; Niels H Gehring; Gabriele Neu-Yilik; Patrick Hundsdoerfer; Margit Pforsich; Ute Frede; Matthias W Hentze; Andreas E Kulozik
Journal:  Blood       Date:  2004-04-01       Impact factor: 22.113

Review 3.  Inherited thrombophilias and adverse pregnancy outcome: screening and management.

Authors:  Michael J Paidas; De-Hui W Ku; Jens Langhoff-Roos; Yale S Arkel
Journal:  Semin Perinatol       Date:  2005-06       Impact factor: 3.300

4.  Mutation screening for the prothrombin variant G20210A by melting point analysis with the Light Cycler system: atypical results, detection of the variant C20209T and possible clinical implications.

Authors:  C Wylenzek; J Trübenbach; P Gohl; G Wildhardt; S Alkins; M B Fausett; J Decker; D Steinberger
Journal:  Clin Lab Haematol       Date:  2005-10

5.  Characterization of a novel prothrombin variant, Prothrombin C20209T, as a modifier of thrombotic risk among African-Americans.

Authors:  H Itakura; M J Telen; C C Hoppe; D A E White; J L Zehnder
Journal:  J Thromb Haemost       Date:  2005-10       Impact factor: 5.824

6.  Atypical melting curve resulting from genetic variation in the 3' untranslated region at position 20218 in the prothrombin gene analyzed with the LightCycler factor II (prothrombin) G20210A assay.

Authors:  Carmen G Tag; Marie-Claire Schifflers; Monika Mohnen; Axel M Gressner; Ralf Weiskirchen
Journal:  Clin Chem       Date:  2005-08       Impact factor: 8.327

7.  Functional analysis of two prothrombin 3'-untranslated region variants: the C20209T variant, mainly found among African-Americans, and the C20209A variant.

Authors:  H H A G M van der Putten; C C Spaargaren-van Riel; R M Bertina; H L Vos
Journal:  J Thromb Haemost       Date:  2006-06-23       Impact factor: 5.824

8.  Atypical mutations of the prothrombin gene at positions 20,209 and 20,218, and a novel mutation at position 20,219. Report on 10 patients.

Authors:  C Flaujac; J Conard; M H Horellou; L Le Flem; M M Samama
Journal:  J Thromb Haemost       Date:  2007-05       Impact factor: 5.824

9.  Mutations in coagulation factors in women with unexplained late fetal loss.

Authors:  I Martinelli; E Taioli; I Cetin; A Marinoni; S Gerosa; M V Villa; M Bozzo; P M Mannucci
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

10.  Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation.

Authors:  Iris Schrijver; Tiffanee J Lenzi; Carol D Jones; Marla J Lay; Maurice L Druzin; James L Zehnder
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.